Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease.

PLoS One · 2021 · PMC8530317 · PMID 34673795

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

a strong trendp = 0.051so close (0.05 < p ≤ 0.1)

Here, we observed a strong trend towards lower troponin levels in patients taking an ARB (p = 0.051).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.